In Brief

In Brief

Daniel Shasha joins Northside Radiation Oncology Consultants

DANIEL SHASHA joined Northside Radiation Oncology Consultants. Shasha is medical director of the radiation oncology program at Northside Hospital Cancer Institute. Shasha has more than 20 years of practice experience in the radiation management of prostate cancer. Most recently, Shasha served as director of genitourinary oncology with Mount Sinai Beth Israel in New York. Shasha... […]
In Brief

Jeff Boyd receives ovarian cancer research award from the Ovarian Cancer Research Fund Alliance

JEFF BOYD received the 2016 Rosalind Franklin Excellence in Ovarian Cancer Research Award from the Ovarian Cancer Research Fund Alliance. Boyd is the director of translational research and genomic medicine for Miami Cancer Institute. The award is named for molecular biologist Rosalind Elsie Franklin, who played a vital role in discovering the structure of DNA.... […]
In Brief

University of Michigan to collaborate with Trovagene Inc.

THE UNIVERSITY OF MICHIGAN Comprehensive Cancer Center and Trovagene Inc. initiated a collaborative research program focused on the Trovera KRAS ctDNA liquid biopsy test in pancreatic cancer. “KRAS gene mutations occur in over 90 percent of pancreatic carcinomas. There is an urgent need for targeted therapies and a precision diagnostic test to identify who would... […]
In Brief

ASTRO names 2016 class of fellows

THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY named 10 members as ASTRO Fellows, in the 10th year that the designation has been awarded. The 2016 class will be recognized at an awards ceremony during ASTRO’s annual meeting Sept. 25-28, in Boston. Fellows have been an active or emeritus member of ASTRO for at least 15 years,... […]
FreeIn Brief

Wistar Institute enters agreement with Christiana Care Graham Cancer Center

THE WISTAR INSTITUTE has entered into an agreement with the Gene Editing Institute at Christiana Care’s Helen F. Graham Cancer Center & Research Institute, expanding their previous partnership established in 2011. The Gene Editing Institute will be integrated into Wistar’s Molecular Screening Facility. The Gene Editing Institute will retain its management structure and will remain […]